SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Genelux Corporation Reports Third Quarter Financial Results and Provides Business Updates

Topline data from Phase 3 OnPrime/GOG-3076 ovarian cancer registrational trial of Olvi-Vec expect

GNLX

Related stories